| | | | | | | |
 | JOHNSON & JOHNSON | 0.39% | 1.50% | -12.80% | -13.09% | 17.46% | 401 004 |
 | NOVO NORDISK A/S | 0.80% | 4.33% | 16.01% | 45.31% | 165.97% | 355 444 |
| ELI LILLY AND COMPANY | 0.43% | 2.42% | -6.47% | 19.49% | 146.66% | 307 267 |
| ABBVIE INC. | 0.23% | 1.69% | -2.06% | -2.36% | 107.75% | 278 593 |
| MERCK & CO., INC. | 0.01% | 1.62% | -4.52% | 29.11% | 37.68% | 268 888 |
 | ROCHE HOLDING AG | 0.21% | 0.89% | -10.09% | -28.72% | -16.83% | 229 429 |
 | ASTRAZENECA PLC | 1.02% | 1.53% | 0.55% | 11.33% | 56.32% | 214 100 |
| NOVARTIS AG | 0.78% | 9.96% | 0.49% | 3.38% | 5.20% | 207 741 |
| BRISTOL-MYERS SQUIBB COMPANY | 1.47% | 1.40% | -3.82% | -5.24% | 24.15% | 143 445 |
 | SANOFI | 0.73% | 3.75% | 11.49% | 8.27% | 24.98% | 135 390 |
| AMGEN INC. | -0.34% | 4.87% | -8.36% | -0.47% | 18.72% | 128 955 |
| GILEAD SCIENCES, INC. | 0.89% | 4.47% | -4.28% | 38.23% | 9.92% | 101 716 |
| GSK PLC | 1.04% | -1.24% | -0.19% | -30.32% | -24.21% | 70 893 |
 | DAIICHI SANKYO CO., LTD. | 1.77% | 2.24% | 13.46% | 79.93% | 94.59% | 68 444 |
 | BAYER AG | 2.04% | 3.29% | 22.01% | -5.06% | 11.56% | 61 902 |
| | | | | | | |
| | Durchschnitt | 0.76% | 2.85% | 0.76% | 9.99% | 45.33% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 0.59% | 2.84% | -1.19% | 9.33% | 59.27% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
